News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
844,766 Results
Type
Article (86340)
Company Profile (642)
Press Release (757784)
Multimedia
Podcasts (123)
Webinars (14)
Section
Business (232550)
Career Advice (4126)
Deals (39696)
Drug Delivery (129)
Drug Development (90933)
Employer Resources (198)
FDA (18082)
Job Trends (17322)
News (396233)
Policy (39730)
Tag
Academia (2998)
Academic (1)
Accelerated approval (6)
Adcomms (29)
Allergies (93)
Alliances (56809)
ALS (98)
Alzheimer's disease (1493)
Antibody-drug conjugate (ADC) (146)
Approvals (18060)
Artificial intelligence (295)
Autoimmune disease (26)
Automation (16)
Bankruptcy (403)
Best Places to Work (12627)
BIOSECURE Act (20)
Biosimilars (117)
Biotechnology (438)
Bladder cancer (85)
Brain cancer (30)
Breast cancer (297)
Cancer (2387)
Cardiovascular disease (198)
Career advice (3534)
Career pathing (34)
CAR-T (170)
Cell therapy (469)
Cervical cancer (21)
Clinical research (73308)
Collaboration (873)
Company closure (1)
Compensation (495)
Complete response letters (25)
COVID-19 (2857)
CRISPR (47)
C-suite (265)
Cystic fibrosis (105)
Data (2247)
Decentralized trials (2)
Denatured (45)
Depression (55)
Diabetes (288)
Diagnostics (6910)
Digital health (19)
Diversity (9)
Diversity, equity & inclusion (48)
Drug discovery (132)
Drug pricing (123)
Drug shortages (33)
Duchenne muscular dystrophy (99)
Earnings (96475)
Editorial (45)
Employer branding (25)
Employer resources (167)
Events (129668)
Executive appointments (770)
FDA (19395)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (773)
Gene editing (115)
Generative AI (27)
Gene therapy (347)
GLP-1 (836)
Government (5144)
Grass and pollen (6)
Guidances (67)
Healthcare (20857)
Huntington's disease (25)
IgA nephropathy (30)
Immunology and inflammation (135)
Indications (30)
Infectious disease (3015)
Inflammatory bowel disease (153)
Inflation Reduction Act (11)
Influenza (53)
Intellectual property (100)
Interviews (812)
IPO (17793)
IRA (50)
Job creations (5187)
Job search strategy (2861)
Kidney cancer (11)
Labor market (41)
Layoffs (543)
Leadership (24)
Legal (10101)
Liver cancer (81)
Lung cancer (342)
Lymphoma (158)
Machine learning (7)
Management (65)
Manufacturing (325)
MASH (75)
Medical device (14625)
Medtech (14630)
Mergers & acquisitions (22423)
Metabolic disorders (764)
Multiple sclerosis (86)
NASH (23)
Neurodegenerative disease (108)
Neuropsychiatric disorders (33)
Neuroscience (2085)
NextGen: Class of 2025 (7662)
Non-profit (5079)
Now hiring (40)
Obesity (408)
Opinion (275)
Ovarian cancer (77)
Pain (94)
Pancreatic cancer (85)
Parkinson's disease (157)
Partnered (22)
Patents (242)
Patient recruitment (116)
Peanut (51)
People (65263)
Pharmaceutical (133)
Pharmacy benefit managers (19)
Phase I (22630)
Phase II (31833)
Phase III (23989)
Pipeline (1232)
Policy (165)
Postmarket research (3552)
Preclinical (10207)
Press Release (72)
Prostate cancer (113)
Psychedelics (37)
Radiopharmaceuticals (269)
Rare diseases (411)
Real estate (7392)
Recruiting (75)
Regulatory (26758)
Reports (57)
Research institute (2653)
Resumes & cover letters (649)
Rett syndrome (5)
RNA editing (4)
RSV (48)
Schizophrenia (80)
Series A (138)
Series B (88)
Service/supplier (25)
Sickle cell disease (57)
Special edition (18)
Spinal muscular atrophy (164)
Sponsored (34)
Startups (4290)
State (2)
Stomach cancer (16)
Supply chain (75)
Tariffs (43)
The Weekly (76)
Vaccines (794)
Venture capitalists (40)
Weight loss (291)
Women's health (40)
Worklife (20)
Date
Today (134)
Last 7 days (898)
Last 30 days (2694)
Last 365 days (34230)
2025 (11115)
2024 (37330)
2023 (42567)
2022 (53928)
2021 (58724)
2020 (57666)
2019 (51338)
2018 (39124)
2017 (37191)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1271)
Alabama (60)
Alaska (7)
Arizona (267)
Arkansas (14)
Asia (50072)
Australia (8828)
California (6257)
Canada (2027)
China (539)
Colorado (271)
Connecticut (300)
Delaware (154)
Europe (114891)
Florida (917)
Georgia (214)
Hawaii (1)
Idaho (64)
Illinois (613)
India (29)
Indiana (331)
Iowa (12)
Japan (165)
Kansas (111)
Kentucky (27)
Louisiana (12)
Maine (67)
Maryland (937)
Massachusetts (4805)
Michigan (240)
Minnesota (413)
Mississippi (2)
Missouri (91)
Montana (31)
Nebraska (26)
Nevada (63)
New Hampshire (69)
New Jersey (1787)
New Mexico (30)
New York (1754)
North Carolina (1100)
North Dakota (9)
Northern California (2698)
Ohio (210)
Oklahoma (15)
Oregon (46)
Pennsylvania (1396)
Puerto Rico (13)
Rhode Island (35)
South America (1652)
South Carolina (23)
South Dakota (1)
Southern California (2296)
Tennessee (95)
Texas (923)
United States (24057)
Utah (185)
Virginia (163)
Washington D.C. (67)
Washington State (589)
West Virginia (3)
Wisconsin (61)
844,766 Results for "eos imaging formerly known as biospace med".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Averna Therapeutics, formerly known as Exsilio Therapeutics, Appoints Thomas M. Barnes, Ph.D., as Chief Executive Officer
January 27, 2025
·
3 min read
Breast cancer
AstraZeneca, Daiichi Sankyo’s ADC Wins First Approval Despite Mixed Data
Datroway, formerly known as Dato-DXd, significantly improved median progression-free survival in a Phase III study but failed to do so for overall survival.
January 21, 2025
·
2 min read
·
Tristan Manalac
GLP-1
BioSpace
Presents the World Atlas of GLP-1s
Eli Lilly and Novo Nordisk are in a global battle for dominance in the weight loss space.
BioSpace
takes a look at the territory covered and what’s to come.
March 26, 2025
·
2 min read
·
Annalee Armstrong
Press Releases
Precision Neuroscience Adds Med-Tech Veterans To Accelerate Commercialization
May 1, 2025
·
3 min read
Press Releases
Henry Meds Brings Hormone Replacement Therapies and Personalized Care to Patients Suffering with Menopause and Perimenopause Symptoms
April 29, 2025
·
2 min read
Job Trends
Getting Jobs Outside of Major Biopharma Hubs Proves Tough,
BioSpace
Finds
Over 80% of those living outside of biopharma’s biggest hubs, like San Diego or Boston, have a tough time finding work, according to a
BioSpace
LinkedIn poll. Biopharma professionals in Oregon and Connecticut and a
BioSpace
recruitment manager share their insights on this issue.
February 27, 2025
·
6 min read
·
Angela Gabriel
Biotech Bay
Henry Meds Revolutionizes Weight Loss Treatment with Oral Tirzepatide Dissolvable Tablets
Telehealth company Henry Meds, known for its commitment to patient-centric care, announced the launch of Compounded Oral Dissolving Tirzepatide Tablets.
May 28, 2024
·
2 min read
Press Releases
Ocugen to Present at the 2025 Cell & Gene Meeting on the Med
April 9, 2025
·
3 min read
Press Releases
iTeos to Present Preclinical Data on Potential Best-In-Class Anti-TREM2 Antibody, EOS-215, and Novel PTPN1/2 Inhibitor at the American Association for Cancer Research Annual Meeting 2025
March 25, 2025
·
4 min read
Weight Loss
Viking Rises as Pfizer’s Oral Obesity Med Falters
Viking Therapeutics enjoyed a nice share rally on the news that rival Pfizer is discontinuing obesity candidate danuglipron. But the biotech has a long way to go to recover after six straight months of decline.
April 14, 2025
·
3 min read
·
Annalee Armstrong
1 of 84,477
Next
